Erratum: Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria

被引：0
|
作者：
Russell P Rother
Scott A Rollins
Christopher F Mojcik
Robert A Brodsky
Leonard Bell
机构：
来源：
Nature Biotechnology | 2007年 / 25卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Nat. Biotechnol. 25, 1256–1264 (2007); published online 7 November 2007; corrected after print 7 December 2007 In the version of this article initially published, on p. 1258, paragraph 2, the incorrect serum concentrations to reach steady state and the incorrect accumulation ratio (Racc) for eculizumab were given.
引用
收藏
页码：1488 / 1488
相关论文
共 50 条
  • [21] Assessing complement blockade in patients with paroxysmal nocturnal hemoglobinuria receiving eculizumab
    de Latour, Regis Peffault
    Fremeaux-Bacchi, Veronique
    Porcher, Raphael
    Xhaard, Alienor
    Rosain, Jeremie
    Castaneda, Diana Cadena
    Vieira-Martins, Paula
    Roncelin, Stephane
    Rodriguez-Otero, Paula
    Plessier, Aurelie
    de Fontbrune, Flore Sicre
    Abbes, Sarah
    Robin, Marie
    Socie, Gerard
    BLOOD, 2015, 125 (05) : 775 - 783
  • [22] Serologic Response to Meningococcal Vaccination in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) for the Chronic Treatment with the Terminal Complement Inhibitor Eculizumab
    Roeth, Alexander
    Alashkar, Ferras
    Herich-Terhuerne, Doerte
    Elias, Johannes
    Vogel, Ulrich
    Duehrsen, Ulrich
    BLOOD, 2014, 124 (21)
  • [23] Treatment of a patient with classical paroxysmal nocturnal hemoglobinuria and Budd-Chiari syndrome, with complement inhibitor eculizumab: Case Report
    Mandala, E.
    Lafaras, C.
    Goulis, I
    Tsioni, K.
    Georgopoulou, V
    Ilonidis, G.
    HIPPOKRATIA, 2013, 17 (01) : 81 - 84
  • [24] Eculizumab (Soliris) for paroxysmal nocturnal hemoglobinuria
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2007, 49 (1270): : 79 - 80
  • [25] Monitoring of patients with paroxysmal nocturnal hemoglobinuria on a complement inhibitor
    Kulasekararaj, Austin G.
    Brodsky, Robert A.
    Hill, Anita
    AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (07) : E232 - E235
  • [26] The Change of Complement Deposition after Complement Inhibitor Treatment in Paroxysmal Nocturnal Hemoglobinuria Patients
    Zhang, Menglu
    Wang, Xuan
    Yang, Chen
    Chen, Miao
    Zhuang, Junling
    Han, Bing
    BLOOD, 2023, 142
  • [27] Long-term effect of the complement inhibitor eculizumab on kidney function in patients with paroxysmal nocturnal hemoglobinuria
    Hillmen, Peter
    Elebute, Modupe
    Kelly, Richard
    Urbano-Ispizua, Alvaro
    Hill, Anita
    Rother, Russell P.
    Khursigara, Gus
    Fu, Chieh-Lin
    Omine, Mitsuhiro
    Browne, Paul
    Rosse, Wendell
    AMERICAN JOURNAL OF HEMATOLOGY, 2010, 85 (08) : 553 - 559
  • [28] Paroxysmal Nocturnal Hemoglobinuria With Budd-Chiari Syndrome Treated With Complement Inhibitor Eculizumab; A Case Report
    Valeri, Federica
    Borchiellini, Alessandra
    Schinco, Piercarla
    Boccadoro, Mario
    BLOOD, 2013, 122 (21)
  • [29] Vaccination of patients with paroxysmal nocturnal hemoglobinuria under eculizumab treatment
    Rodriguez-Garcia, Juan
    Fernandez-Santos, Rafael
    Antonio Garcia-Erce, Jose
    MEDICINA CLINICA, 2012, 138 (14): : 640 - 641
  • [30] Eculizumab opens a new era of treatment for paroxysmal nocturnal hemoglobinuria
    Schrezenmeier, Hubert
    Hoechsmann, Britta
    EXPERT REVIEW OF HEMATOLOGY, 2009, 2 (01) : 7 - 16
12345